Terms: = Lymphoma AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Prognosis
21 results:
1. Angiogenesis' related genetic variants alter clinical features and prognosis of diffuse large B-cell lymphoma patients.
Brito ABC; Delamain MT; Fanelli MF; Soares FA; de Souza CA; Vassallo J; Lima CSP
Tumour Biol; 2021; 43(1):129-140. PubMed ID: 34219681
[TBL] [Abstract] [Full Text] [Related]
2. vegfr2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B-cell lymphoma.
Kaddu-Mulindwa D; Rosolowski M; Ziepert M; Regitz E; Assmann G; Bewarder M; Held G; Pfreundschuh M; Bittenbring JT
Eur J Haematol; 2021 Jan; 106(1):100-104. PubMed ID: 32997825
[TBL] [Abstract] [Full Text] [Related]
3. MiR-139-5p regulates vegfr and downstream signaling pathways to inhibit the development of esophageal cancer.
Jiao W; Zhang J; Wei Y; Feng J; Ma M; Zhao H; Wang L; Jiao W
Dig Liver Dis; 2019 Jan; 51(1):149-156. PubMed ID: 30245290
[TBL] [Abstract] [Full Text] [Related]
4. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
[TBL] [Abstract] [Full Text] [Related]
5. Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival.
Guillem V; Calabuig M; Brunet S; Esteve J; Escoda L; Gallardo D; Ribera JM; Queipo de Llano MP; Arnan M; Pedro C; Amigo ML; Martí-Tutusaus JM; García-Guiñón A; Bargay J; Sampol A; Salamero O; Font L; Talarn C; Hoyos M; Díaz-Beyá M; Garrido A; Navarro B; Nomdédeu J; Sierra J; Tormo M
Leuk Lymphoma; 2018 Oct; 59(10):2383-2393. PubMed ID: 29345176
[TBL] [Abstract] [Full Text] [Related]
6. Strong Anti-tumorous Potential of Nardostachys jatamansi Rhizome Extract on Glioblastoma and In Silico Analysis of its Molecular Drug Targets.
Kapoor H; Yadav N; Chopra M; Mahapatra SC; Agrawal V
Curr Cancer Drug Targets; 2017; 17(1):74-88. PubMed ID: 27774879
[TBL] [Abstract] [Full Text] [Related]
7. Ponatinib reduces viability, migration, and functionality of human endothelial cells.
Gover-Proaktor A; Granot G; Shapira S; Raz O; Pasvolsky O; Nagler A; Lev DL; Inbal A; Lubin I; Raanani P; Leader A
Leuk Lymphoma; 2017 Jun; 58(6):1455-1467. PubMed ID: 27733071
[TBL] [Abstract] [Full Text] [Related]
8. Emerging tyrosine kinase inhibitors for the treatment of renal cancer.
Iacovelli R; Albiges L; Escudier B
Expert Opin Emerg Drugs; 2015 Sep; 20(3):379-92. PubMed ID: 25982181
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-A, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical Hodgkin lymphoma.
Dimtsas GS; Georgiadi EC; Karakitsos P; Vassilakopoulos TP; Thymara I; Korkolopoulou P; Patsouris E; Kittas C; Doussis-Anagnostopoulou IA
Leuk Lymphoma; 2014 Mar; 55(3):558-64. PubMed ID: 23772669
[TBL] [Abstract] [Full Text] [Related]
10. Microvessel density and expression of vascular endothelial growth factor and its receptors in different subtypes of primary cutaneous B-cell lymphoma.
Wobser M; Siedel C; Kneitz H; Bröcker EB; Goebeler M; Houben R; Geissinger E
Acta Derm Venereol; 2013 Nov; 93(6):656-62. PubMed ID: 23624620
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic significance of vascular endothelial growth factor expression in adult patients with acute myeloid leukemia: a meta-analysis.
Guo B; Liu Y; Tan X; Cen H
Leuk Lymphoma; 2013 Jul; 54(7):1418-25. PubMed ID: 23157271
[TBL] [Abstract] [Full Text] [Related]
12. Role of VEGF/vegfr in the pathogenesis of leukemias and as treatment targets (Review).
Song G; Li Y; Jiang G
Oncol Rep; 2012 Dec; 28(6):1935-44. PubMed ID: 22993103
[TBL] [Abstract] [Full Text] [Related]
13. [Plasma levels of VEGF-C, VEGF-D, vegfr-2 and vegfr-3 in patients with newly diagnosed lymphomas].
Liu F; Song YQ; Zhang C; Fu ZY; Ping LY; Ying ZT; Zheng W; Wang XP; Xie Y; Lin NJ; Tu MF; Zhu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1184-8. PubMed ID: 22040968
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of lymphangiogenic markers in Sézary syndrome.
Karpova MB; Fujii K; Jenni D; Dummer R; Urosevic-Maiwald M
Leuk Lymphoma; 2011 Mar; 52(3):491-501. PubMed ID: 20846094
[TBL] [Abstract] [Full Text] [Related]
15. [Current developments and perspectives in targeted therapies].
Dickgreber N; Huber RM; Reck M; Reinmuth N; Schütte W; Serke M; Wolf J
Onkologie; 2010; 33 Suppl 5():2-11. PubMed ID: 20523101
[TBL] [Abstract] [Full Text] [Related]
16. High dose chemoradiotherapy and ASCT may overcome the prognostic importance of biologic markers in relapsed/refractory Hodgkin lymphoma.
Persky DO; Moskowitz CH; Filatov A; Saxena R; Cui H; Teruya-Feldstein J
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):35-40. PubMed ID: 19701081
[TBL] [Abstract] [Full Text] [Related]
17. [Clinical importance of angiogenesis and angiogenic factors in oncohematology].
Grosicki S; Grosicka A; Hołowiecki J
Wiad Lek; 2007; 60(1-2):39-46. PubMed ID: 17607967
[TBL] [Abstract] [Full Text] [Related]
18. Vascular endothelial growth factor C--a potent risk factor in childhood acute lymphoblastic leukaemia: an immunocytochemical approach.
Nowicki M; Ostalska-Nowicka D; Kaczmarek E; Miskowiak B; Witt M
Histopathology; 2006 Aug; 49(2):170-7. PubMed ID: 16879394
[TBL] [Abstract] [Full Text] [Related]
19. Placenta growth factor stimulates the growth of Philadelphia chromosome positive acute lymphoblastic leukemia cells by both autocrine and paracrine pathways.
Ikai T; Miwa H; Shikami M; Hiramatsu A; Tajima E; Yamamoto H; Imai N; Hattori A; Nishii K; Miura K; Satoh A; Itoh M; Imamura A; Mihara H; Katoh Y; Nitta M
Eur J Haematol; 2005 Oct; 75(4):273-9. PubMed ID: 16146532
[TBL] [Abstract] [Full Text] [Related]
20. Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia.
Faderl S; Do KA; Johnson MM; Keating M; O'brien S; Jilani I; Ferrajoli A; Ravandi-Kashani F; Aguilar C; Dey A; Thomas DA; Giles FJ; Kantarjian HM; Albitar M
Blood; 2005 Dec; 106(13):4303-7. PubMed ID: 16123221
[TBL] [Abstract] [Full Text] [Related]
[Next]
